Strasburger Lab
Pregnant Volunteers Needed: Research Study Looks at Possible Risk Factors for Stillbirth
Each year around 24,000 Babies are Stillborn in the United States. In many, the cause is unclear.
Volunteers are needed to participate in a paid National Institutes of Health (NIH) Study conducted by Professor JF Strasburger and Professor RT Wakai, to learn more about fetal heart findings in the following high risk pregnancy conditions:
- History of Stillbirth after 20 weeks gestation
- Fetal Congenital Heart Defects
- Gastroschisis
- Hydrops Fetalis
- Mono Twin Pregnancy
To be eligible you must be at least 18 years or older AND currently 4 to 9 months pregnant.
The study involves 2 visits of 1 to 3 hours each at the Wisconsin Institute of Medical Research (WIMR) on the UW Madison Medical Campus. You are compensated for your time.
After your baby is born, an ECG will be performed within the first 4 weeks of your baby’s birth.
If you would like to participate in this study, please contact Gretchen Eckstein, BSN, Study Coordinator at (414) 266-3539.
We encourage you to discuss this study (Clinical Trials.gov, NCT# 03775954) and any other study with your provider before participating.
Learn More About Our Work
Article on fMCG in Connexions
Scientific Statement
SADS Talk
FDA Talk
A message from Dr. Strasburger
Dr. Strasburger joined the ϰϲͼ, Children's Hospital of Wisconsin in January 2002 after practicing 14 years in Pediatric Cardiology and Electrophysiology at Children's Memorial Hospital, Northwestern University, in Chicago, IL.
Dr. Strasburger performs research in the area of pre-natal evaluation of arrhythmias in the fetus.
"I am recognized for my clinical and research contributions to electrophysiology, fetal echocardiography, and fetal arrhythmia diagnosis and management. I am a member of the writing committee for the 2014 and ~2022 American Heart Association (AHA) Scientific Statement on Fetal Diagnosis and Treatment (Donofrio, Circulation 2014, and TBD date). I am also a member of the writing group for the 2022 Heart Rhythm Society’s Consensus Statement on Antiarrhythmic Drug Therapy in Pregnancy. I was an invited speaker for the Oct 21-22, 2021 FDA Public Workshop on Fetal Pharmacology and Therapeutics. I have been an ad-hoc reviewer for several NIH study sections, including Large Instrumentation (2009), special emphasis panels ZRG1 SBIB-V (82) S (2015, 2016, 2017), and ZRG1 SBIB-V(55) (2015, 2016), and Pediatric and Obstetrical Pharmacology ZRG1 EMNR-S (54, 55) (2019, 2020, 2021, 2022) the Human Placenta Project grants, and PRMIS Discovery Grant Review Panel for the Department of Defense (2020).
Janette Strasburger, MD